KALY-Kali-Extracts RespRx Could Offer Treatment For Coronavirus Symptoms
January 28 2020 - 11:14AM
InvestorsHub NewsWire
KALY-Kali-Extracts RespRx Could
Offer Treatment For Coronavirus Symptoms
Dallas, TX --
January 28, 2020 -- InvestorsHub NewsWire -- Kali-Extracts, Inc.
(Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC:
KALY) (“KALY”) today highlighted that its RespRx CBD
formulation could offer treatment for coronavirus symptoms.
KALY’s CBD formulation has been developed for the treatment
of symptoms associated with
Chronic Obstructive Pulmonary Disease
(COPD) and other similar respiratory
conditions. The
formulation for the treatment of symptoms associated with COPD and
other similar respiratory conditions has been derived from the
company’s U.S. Patented Cannabis Extraction Process. In conjunction
with the research already conducted and the next phase of research
now moving forward, KALY has filed a new patent application
specifically on its CPD formulation for symptoms associated with
COPD and other similar respiratory
conditions. KALY has also filed for a trademark
on the name RespRx
as the brand name for its
CBD formulation to treat the symptoms associated with COPD and
other similar respiratory
conditions.
From
The World Health
Organization:
“Coronaviruses
(CoV) are a large family of viruses that cause illness ranging from
the common cold to more severe diseases such as Middle East
Respiratory Syndrome (MERS-CoV) and Severe Acute
Respiratory Syndrome (SARS-CoV). A novel coronavirus
(nCoV) is a new strain that has not been previously identified
in humans."
“Common signs
of infection include respiratory symptoms, fever, cough, shortness
of breath and breathing difficulties. In more severe cases,
infection can cause pneumonia, severe acute respiratory syndrome,
kidney failure and even
death.”
A potential strategic investor engaged with KALY
regarding the company’s recently
announced consolidation of its
business structure to focus on its Cannabis Biopharmaceutical
Technology is coordinating with KALY management to facilitate a
potential research liaison with organizations addressing the
current coronavirus outbreak.
To learn more about RespRx,
visit https://www.resprx.com/
Follow further
developments at
https://www.kali-extracts.com/
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and as such, may involve risks and uncertainties.
These forward looking statements relate to, amongst other things,
current expectation of the business environment in which the
company operates, potential future performance, projections of
future performance and the perceived opportunities in the market.
The company's actual performance, results and achievements may
differ materially from the expressed or implied in such
forward-looking statements as a result of a wide range of
factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214)
210-0459
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Sep 2023 to Sep 2024